Your browser version may not work well with NCBI's Web applications. More information here...
1: J Biol Chem. 2006 May 12;281(19):13030-7. Epub 2006 Mar 14.Click here to read Links
Erratum in:
J Biol Chem. 2006 Jun 23;281(25):17540.

Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference.

Weber C, Mello de Queiroz F, Downie BR, Suckow A, Stühmer W, Pardo LA.

Max Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Göttingen, Germany.

EagI potassium channels are natively expressed in the mammalian brain as well as in many cancer cell lines and tumor tissues. The role of EagI in malignant transformation has been suggested by several experiments, but the lack of specific EagI inhibitors has made it difficult to examine the influence of the channel on oncogenesis and its potential as a therapeutic target. We have used short interfering RNA to test the effects of EagI reduction on the behavior of tumor cells in vitro. By generating and optimizing an EagI-specific short interfering RNA system, we were able to study the effects of EagI depletion on several cancer cell lines that endogenously express this protein. We show here that our short interfering RNA sequences act specifically on EagI, reproducibly induce a significant decrease in the proliferation of tumor cell lines, and do not trigger any observable nonspecific responses.

PMID: 16537547 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Potassium (Glu-K® , K+ 10® , K+ 8® , ...)

    Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney dis...

  • Source: AHFS Consumer Medication Information